Skip to main content
GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.109
+0.017 (18.48%)
At close: Mar 9, 2026

GenSight Biologics Revenue

GenSight Biologics had revenue of 48.00K EUR in the half year ending June 30, 2025, a decrease of -98.23%. This brings the company's revenue in the last twelve months to 945.00K, down -52.18% year-over-year. In the year 2024, GenSight Biologics had annual revenue of 2.63M, down -11.44%.

Revenue (ttm)
945.00K
Revenue Growth
-52.18%
P/S Ratio
21.47
Revenue / Employee
72.69K
Employees
13
Market Cap
20.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.63M-339.00K-11.44%
Dec 31, 20232.96M-1.90M-39.08%
Dec 31, 20224.87M-2.84M-36.89%
Dec 31, 20217.71M269.00K3.62%
Dec 31, 20207.44M2.53M51.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
genOway Société anonyme 27.16M
Aelis Farma 2.33M
Advicenne 5.90M
NFL Biosciences 164.00
Poxel 7.66M
Fermentalg 12.78M
Oncodesign Precision Medicine Société anonyme 1.74M
Nicox 3.32M
Revenue Rankings

GenSight Biologics News

More News